The market for hallux rigidus, a big toe degenerative arthritis, shows interesting developments. An aging population, knowledge, and improved therapies cause these trends. Hallux rigidus stiffens the big toe. Both non-surgical and surgical treatments have improved.
Older age increases the risk of hallux rigidus. The global population ages, increasing the risk of this illness. As more individuals with hallux rigidus symptoms including discomfort, restricted joint mobility, and problems walking seek treatment, the market reacts.
Advanced hallux rigidus therapies without surgery are becoming increasingly popular. Conservative treatments including braces, physical therapy, and anti-inflammatory medicines are being studied more and more to manage symptoms and halt disease progression. This tendency matches the demand for early intervention and non-surgical treatments.
Not only are non-surgical hallux rigidus treatments becoming increasingly popular, but so are somewhat invasive surgeries. Surgery like cheilectomy removes bone spurs, and joint-preserving therapies relieve symptoms while maintaining joint function. Surgery advances have shortened recovery periods and improved patient outcomes.
Market trends are evolving as MRI and ultrasound technology improve. Hallux rigidus treatment requires a proper and early diagnosis. These technologies enable healthcare practitioners assess joint deterioration and choose a therapy.
Hallux rigidus awareness campaigns and training programs assist detect and treat the problem early. Patients are learning about their illness, risk factors, and treatment options. This information makes people more inclined to seek medical treatment, which benefits the market.
Hallux rigidus is prevalent worldwide, hence its market is rising. In certain populations, lifestyle changes, shoe habits, and family inclination make it more prevalent. The global market's rise allows healthcare personnel and manufacturers to address several medical demands.
Current biomechanics research is generating novel hallux rigidus injury treatments. Treatments that address the issue need knowledge of foot physics and big toe joint forces. New research concepts modify treatment procedures.
Despite advancements, hallux rigidus devices are still difficult to produce. New gadget designs and materials are required for long-term pain alleviation and joint health. These issues must be overcome for hallux rigidus therapy to progress.
The Hallux Rigidus Market Size was valued at USD 4.10 Billion in 2023. The Global Hallux Rigidus industry is projected to grow from USD 4.51 Billion in 2024 to USD 9.07 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.06% during the forecast period (2024 - 2032). Hallux rigidus is an arthritic condition often leading to pain and stiffness within the joint located behind the big toe. Hallux rigidus is a syndrome related to degeneration of the first MTP joint. It leads to a limitation in joint range of motion and painful ambulation.
Hallux rigidus can be caused by either a traumatic injury or through overuse of the foot. Overpronation or too much stress on the joint is one of the reasons. Repetitive weight bearing in a dorsiflexed position such as when walking up mountains or driving forward in a rugby scrum or similar conditions can be a factor.
Other causes include traumatic injury such as stubbing the big toe causing cartilage damage in the joint. Rheumatoid arthritis which is inflammatory wear and tear of the joint, as well as gout which is a form of arthritis caused by excessive uric acid in the joint, can also cause hallux rigidus.
The hallux rigidus market is majorly driven by increasing geriatric population, rising diabetic mass, and rising road mishaps. According to the U.S. Population Reference Bureau, the number of Americans aged 65 and older is projected to 98 million by 2060 from 46 million as of 2014. Similarly, the 65-and-older age group will rise to nearly 24 percent by 2030 from 15 percent as of 2015.
Segments
The hallux rigidus infection market is segmented on the basis of treatment, diagnosis, and end-users.
On the basis of the treatment, the market is segmented into non-surgical treatment and surgical treatment. Further, the non-surgical treatment is sub-segmented into shoe modifications, orthotic devices, medications, injection therapy, and physical therapy. And the surgical treatment is sub-segmented into bone spur removal (cheilectomy), joint fusion (arthrodesis), joint resurfacing (interpositional arthroplasty), and joint replacement (arthroplasty).
On the basis of diagnosis, the Hallux Rigidus Market is segmented into X-ray, CT scan, and MRI.
On the basis of the end users, the market is segmented into hospitals & surgical centers, home cares, and orthopedic specialty clinics.
Regional Analysis
North America holds the maximum share of hallux rigidus market in the Americas region. On a regional basis, Americas region is segmented into North America and South America. North America is segmented into the U.S. and Canada. Increasing number of geriatric population and growing diabetic mass has increased the scope of the market in North America.
Europe holds the second largest share in the market. The European market is expected to observe a healthy growth during the forecasted period. Factors such as availability of advanced treatment facilities, and skilled medical professionals is propelling the growth of hallux rigidus market in Europe. Additionally, increasing government funding and extensive research and development in terms of healthcare is likely to boost the market growth.
Asia Pacific is expected to be the fastest growing market owing to increasing prevalence of chronic diseases such as diabetes is the major driver for the market growth. India is the fastest growing region owing to an increasing population. Rising awareness about the health and availability of new treatment methods is likely to drive the market in this region.
The Middle East & Africa is expected to show a slow growth in the market . Major factors that are hampering the growth are lack of awareness, and limited access and availability of treatment facilities. In the Middle East, United Arab Emirates has garnered the largest market share owing to the development of healthcare industry and rising number of specialty care centers.
Key Players
Some of the key players in Hallux Rigidus Market are DePuy Synthes Companies, Stryker, Zimmer Biomet, Smith & Nephew, Wright Medical Group N.V., Advanced Orthopaedic Solutions, Integra LifeSciences Corporation, and Acumed, Bioretec Ltd. among others.
Intended Audience
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)